Hemodynamic and Cardiac Effects of Nicardipine in Patients with Coronary Artery Disease

The hemodynamic and cardiac effects of the calcium antagonist nicardipine, alone (n = 10 patients) or combined with propranolol (0.1 mg/kg i.v.; n = 9 patients), were assessed in patients with coronary artery disease. In the absence of β-blockade, nicardipine (5 or 10 mg i.v.) increased heart rate (...

Ausführliche Beschreibung